An eosinophil leukocyte chemotactic factor of anaphylaxis
about
Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2alpha on pulmonary mechanics in the guinea pig.Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxisEoL-1, a human eosinophilic cell line.Leukotaxis and leukotactic disorders. A reviewModulation of human eosinophil polymorphonuclear leukocyte migration and functionA role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serumThe selective eosinophil chemotactic activity of histamine.Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxisChemokines active on eosinophils: potential roles in allergic inflammation.New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting.Effects of corticosteroids on eosinophil chemotaxis and adherence.Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice.Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lungPhagocytosis: a review.Mast cells in allergic diseases and mastocytosis.Suppression of reaginic antibodies.The inflammatory mediators.Neutrophil chemotaxis.State--and dynamics--of the art: a current review. IgE-mediated immediate hypersensitivity reactions: cellular events and pharmacologic mediators.Suppression of IgE antibodies with conjugates of haptens or allergens and synthetic hydrophilic polymers.Control of cellular influx in lung and its role in pulmonary toxicology.The eosinophilic granulocyte.The human eosinophil: roles in host defense and tissue injury.Eosinophilic granulocytes and skin disorders.Eosinophil, eosinophilia, and eosinophilic disorders.Functions of the eosinophil leucocyte.Mechanisms of eosinophil recruitment.Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cellsBasophilic leukocytes in allergic contact dermatitis.Blood eosinophils and eosinophil cationic protein after acute myocardial infarction or corticosteroid administration.Experimental production of pulmonary granulomas. IV. Eosinophilic granuloma.Activation of basophil and mast cell histamine release by eosinophil granule major basic protein.Schistosoma mansoni: cellular reactions to challenge infections in the cheek pouch skin of chronically infected Chinese hamsters.Inhibition of eosinophil chemotaxis by the antagonist of slow reacting substance of anaphylaxis--compound FPL 55712.Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration.Active cutaneous anaphylaxis in the guinea-pig. Immunological and inflammatory reactions.Broncho-alveolar leucocyte responses during primary and secondary Nippostrongylus brasiliensis infection in the rat.Eosinophils in Nasal Secretion
P2860
Q34519374-89044D3B-60E3-442B-8EE0-16BB51BEC225Q34612311-BF9E4259-FF43-414F-A50A-E6966B874C91Q35092324-806DA8D5-96C2-43A6-8254-D7F1CC392377Q35653574-E2EEBD31-B2D8-4C8C-9D66-C71AC3FA6BD9Q35875620-CDC78447-B2F3-4A91-85E0-4E37F40AD726Q36078173-49BBA9CC-B5DB-4480-AD3F-645AA57D7053Q36358512-53E06930-D169-4E9E-8DE5-5A2C5EE10DBEQ36358850-C9282AB4-D1B4-497E-AE29-6670F456EEA0Q36360104-E56B9062-D06A-4D9F-B4BA-877E18BD5FF5Q36366779-6FE1B552-4A40-48B6-B7F9-975DC8DD6C03Q36587795-09721093-DD51-47F0-84F1-6CF76C1D6D60Q37025367-EEC587D8-B52A-4B94-8AE9-EE7F2B3CABF5Q37028014-F0462E4A-9F25-47ED-BC4B-5F6C2E31418AQ37046801-B23EA9FA-4AB4-45DB-AD9F-89BFEC62C933Q37052212-B7152659-C494-49E8-8C7B-73507A63858EQ37811722-D8AC898C-6628-4187-A15D-031CC49D4D41Q39399589-57AF3EC9-F9C6-4282-BE98-7D033AD97C99Q39513160-68758D12-E3DD-40D2-8AD9-77083E67E989Q39870275-63D91AB8-52B4-4087-9A1B-B653B827B206Q40098113-C5A179F8-2B6A-403C-A688-8A02D933607BQ40107132-9F3BCF58-8406-4693-B568-03335F7B2C4AQ40113617-0CC75555-37B3-4E91-B8BD-D58D67751DACQ40179987-61DFF560-7E2C-45AE-9C37-9C29843A9AD8Q40198229-C40CCD1A-C091-4E6D-AB16-F48D171ED5A2Q40290821-E44F1304-4F75-4A22-8996-130F72E07FCBQ40320192-6B4F6ACB-8179-4E7B-81EE-E19F09AE62D2Q40323728-82756B57-00A3-4407-8130-C46ACAA9DEE1Q40532091-C2587585-B3C9-41CA-8C9C-EC20B2097BEAQ40898276-D29EB99B-5FD6-4224-89EF-CBE9AD4BE75FQ41240545-E4F30389-2B1D-45B6-A170-17914C5F88B1Q41519387-9E3FFEF6-8C89-4243-89C7-038F3DA8CC7DQ41724877-3CBDFBB9-34C6-4366-9E6C-DDBB9AA2F7AEQ41887651-2B711161-2853-4F34-9082-BCCCCB5E12BBQ41991407-95A9B73B-ECD2-42F9-960F-9528CF48C53DQ43980888-C32F5E5D-3C35-436A-8B51-D92660D823FBQ46387793-DEE2B72B-CA3C-4248-9237-9774D568ACACQ46900238-E36F83A0-184B-4560-BC93-BB9BB30EE535Q54022105-E52D7383-A71B-4174-90B0-7FE5BD039B98Q54474621-C1E0FAF9-562F-46D3-BB75-A04A54F3A355Q58272906-2277B30D-8860-443D-A321-CB60F58A0201
P2860
An eosinophil leukocyte chemotactic factor of anaphylaxis
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh
1971年學術文章
@zh-hant
name
An eosinophil leukocyte chemotactic factor of anaphylaxis
@ast
An eosinophil leukocyte chemotactic factor of anaphylaxis
@en
type
label
An eosinophil leukocyte chemotactic factor of anaphylaxis
@ast
An eosinophil leukocyte chemotactic factor of anaphylaxis
@en
prefLabel
An eosinophil leukocyte chemotactic factor of anaphylaxis
@ast
An eosinophil leukocyte chemotactic factor of anaphylaxis
@en
P2093
P2860
P356
P1476
An eosinophil leukocyte chemotactic factor of anaphylaxis
@en
P2093
Stechschulte DJ
P2860
P304
P356
10.1084/JEM.133.3.602
P407
P577
1971-03-01T00:00:00Z